Cancer costs and outcomes in the Finnish population 2004–2014

Figures & data

Table 1. Summary of costs and population level measures (nominal prices) for 2004 and 2014 in Finland.

	2004 nominal cost in million €	2014 nominal cost in million €	Annual change
Costs of care (77.6%)
Inpatient episodes in secondary care	240	202	–2%
Outpatient visits in secondary care	106	283	+10%
Inpatient episodes in primary and private care	70	87	+2%
Rehabilitation	4	4	+0%
Outpatient medication	60	160	+10%
Indirect costs (17.8%)
Disability pensions	80	76	–1%
Sick leave reimbursements	46	58	+2%
Travelling costs	15	17	+1%
Screening (4.6% of total costs)
Screening	26	39	+4%
Total costs
Total	646	927	+4%
Population level measures
Population	5,236,611	5,471,753	+0%
Total healthcare expenditure (million €)	11,240	20,527	+6%
Number of new cancer patients	26,847	32,311	+2%

Figure 1. The deflated costs of cancer by cost drivers for 2004, 2009 and 2014, 2004 = 100.

Figure 2. Actual nominal costs compared to the national estimates made in 2006 [8].

Figure 3. The costs of cancer and the outcome measures of care for 2004, 2009 and 2014. 2004 = 1. *Survival ratio year means the observation year.

Table 2. Summary of cost trends in previous studies of cost of cancer and the results of this study.

Study	Country	Costs included in the study	Years (observed or projected)	Average annual change (%) in real costs	Average annual change in Finland 2004–2014 in real costs
Mariotto et al. [6]	USA	•Treatment costs in 2001–2006 for over-65-year-olds	2010 (prediction)–2020 (prediction)	2.4% (if constant treatment costs) 3.2% (if treatment costs increase by 2% annually)	2.4% treatment costs
Tangka et al. [9]	USA	•Treatment costs	1987–2003	4.2%
NHS England 2013 [19]	England	•Treatment costs	2004–2013 (observed)	3.6%
Ministerie van Volksgezondheid, Welzijn en Sport 2011 [20]	The Netherlands	•Treatment costs (OECD SHA definitions)	2003–2011 (observed)	4.0%
Torkki et al. [18]	Finland	•Treatment costs in secondary care	2008–2013 (observed)	3.2%
Institutet för Hälso- och Sjukvårdsekonomi 2016 [7]	Sweden	•Treatment costs (including screening) •Productivity costs due to mortality, sick leave and reduced working ability •Cost of informal caregiving	2013 (observed)–2020, 2030, 2040 (prediction)	2013–2020: 3.0% 2013–2030: 2.7% 2013–2040: 2.4%	1.7% total costs
Mäklin and Rissanen [8]	Finland	•Treatment costs (including screening) •Productivity costs due to sick leave and disability pensions	1996–2004 (observed)–2015 (three predictions)	1996–2004: 4.2% 2004–2015: regression 2.6%, expert 4.9%, exponential 8.5%

Mäklin S, Rissanen P. Syöpien aiheuttamat kustannukset: Hoito- ja tuottavuuskustannusten kehitys vuosina 1996–2004 ja ennuste niiden muutoksista vuoteen 2015. Suomen Syöpäyhdistyksen Julkaisuja [Cost of cancer 1996–2014 and predictions for year 2015]. Cancer Soc Finland. 2006;67. Finnish.

 Google Scholar

Mariotto AB, Yabroff KR, Shao Y, et al. Projections of the cost of cancer care in the United States: 2010–2020. J Natl Cancer Inst. 2011;103:117–128.

 PubMed Web of Science ®Google Scholar

Tangka FK, Trogdon JG, Richardson LC, et al. Cancer treatment cost in the United States: has the burden shifted over time? Cancer. 2010;116:3477–3484.

 PubMed Web of Science ®Google Scholar

NHS England. Programme Budgeting Aggregate PCT Expenditure for all programmes and subcategories for financial years 2003/04 to 2012/13. Available from: https://www.networks.nhs.uk/nhs-networks/health-investment-network/documents/Programme%20Budgeting%20Aggregate%20PCT%20figure%202003-04%20to%202012-13.xls

 Google Scholar

Ministerie van Volksgezondheid, Welzijn en Sport. Cost of illness in the Netherlands; 2011. Available from: https://costofillnesstool.volksgezondheidenzorg.info/tool/english/

 Google Scholar

Torkki P, Leskelä RL, Rytkönen A, et al. Syövän hoidon kustannusten kehitys 2008–2013 Keski-Suomen sairaanhoitopiirissä [Cost of cancer treatment 2008–2013 in Central Finland Hospital District]. Duodecim. 2015;24:2367–2373. Finnish.

 Google Scholar

IHE – Institutet för Hälso- och Sjukvårdsekonomi. Kostnader för cancer I Sverige idag och år 2040. IHE Rapport; 2016, vol. 1. Available from: http://res.cloudinary.com/cancerfonden/image/upload/v1459776752/documents/ihe-rapport-2016.pdf

 Google Scholar